|Articles|August 1, 2009
- BioPharm International-08-01-2009
- Volume 22
- Issue 8
BioPharm International, August 2009 (PDF)
Pfizer Tackles Lean and Six Sigma
Advertisement
Articles in this issue
over 16 years ago
Use of Change-Point Analysis for Process Monitoring and Controlover 16 years ago
Analytical Tools for Process and Product Characterizationover 16 years ago
Laying the Foundationover 16 years ago
Waiting for Godot: Will Venture Funding Return?over 16 years ago
Health Reform Challenges Biotech Industryover 16 years ago
Avoiding the Regulatory Catch 22Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Formulation Strategies, Tech Advances, Challenges, and Considerations in Novel Drug Delivery
2
Op-Ed: Why the US Must Move Beyond Its mRNA Monoculture
3
How New ADC Modalities Backed by Samsung Could Shape Solid Tumor Treatment
4
What a $2 Billion Maryland Expansion Means for the Future of Biologics Production
5
